Elekta's New Radiation Oncology Technology to Shape the Future of Cancer Care

Mon Feb 4, 2013 9:00am EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130204:nPnCL42701

Worldwide unveiling of radiation delivery technology will be held March 1 in
Atlanta, USA


ATLANTA  and  STOCKHOLM,  Feb. 4, 2013  /PRNewswire/ -- At an exclusive event
scheduled  March 1, 2013, Elekta will reveal a leap forward in radiation
oncology and the care of individuals with cancer worldwide.  

Founded in 1972, Elekta was the first to bring a completely digital linear
accelerator to the market, as well as the first to fully integrate imaging
technology in the treatment system. Elekta is a market-leading developer of
cancer care and neuroscience solutions, including a world-class portfolio of
linear accelerators, dedicated radiosurgery and brachytherapy systems and
oncology information and treatment planning software solutions.

"At Elekta, we are united by a passion that drives us to constantly strive
toward the development of new cancer care solutions that benefit patients,
caregivers and healthcare systems," says Elekta's President and CEO  Tomas
Puusepp. "It is this unrelenting dedication to patients and their healthcare
providers that has inspired our efforts to create a truly singular technological
solution in radiation oncology."

The worldwide unveiling event will be held  Friday, March 1  at the Renaissance
Atlanta Waverly Hotel,  Atlanta, Georgia, USA,  11 a.m. - 12 p.m. EST. To attend
or view live online, register at  www.elekta.com/revealed.

*Availability of product will be subject to local regulatory clearance.

 For further information, please contact:                                         
 Johan Andersson Melbi, Director, Investor Relations, Elekta AB                   
 Tel: +46 702 100 451, email:  johan.anderssonmelbi@elekta.com                    
 Time zone: CET: Central European Time                                            
                                                                                  
 Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta  
 Tel: +1 770-670-2447, email:  michelle.joiner@elekta.com                         
 Time zone: ET: Eastern Time                                                      


About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both healthcare providers and patients,
Elekta aims to improve, prolong and even save patient lives.  

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,400 employees globally. The
corporate headquarters is located in  Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker EKTAb. Website:  www.elekta.com.

SOURCE  Elekta

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.